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TO THE EDITOR
Bullous pemphigoid (BP) is an auto-
immune bullous disease of the elderly,
characterized by subepidermal blister
formation. Patients with BP have circu-
lating and tissue-bound antibodies
directed against antigens of the dermal–
epidermal junction, including BP230
(BPAG1) and BP180 (BPAG2) (Kasper-
kiewicz and Zillikens, 2007). Binding
of autoantibodies initiates an inflam-
matory cascade resulting in dermal–
epidermal separation and blister. An
essential role of neutrophils in the
pathogenesis of BP has been demon-
strated in mouse studies in vivo (Liu
et al., 1997). In BP patients, eosinophils
and, to a lesser extent, neutrophils
are found in lesional skin (Borrego
et al., 1996). There is increasing
evidence that eosinophils may contri-
bute to the pathogenesis of the human
disease (Zone et al., 2007), whereas
neutrophils have been reported to be
important for dermal–epidermal separa-
tion in an ex vivo model using BP
patient’s serum and cryosections of
human skin (Gammon et al., 1982;
Sitaru et al., 2002a, b).
Neutrophil activation in BP is
supposed to be a consequence of
Fcg receptor (FcgR) binding to immune
complexes (ICs) (Sitaru et al., 2002a, b;
Zhao et al., 2006). Using neonatal
mice deficient in different genes for
FcgRs, Zhao et al. (2006) showed that
FcgRIII is required for neutrophil
activation and subsequent disease
development in a passive transfer
mouse model of BP. However, the
relevance of these findings and their
impact on the disease in humans has
not been evaluated. In addition, mice
and man differ significantly in their
FcgRs with regard to cell-specific ex-
pression and cellular functions. Quies-
cent human neutrophils express
FcgRIIA and FcgRIIIB (Li et al., 1996;
Veri et al., 2007), whereas quiescent
murine neutrophils express FcgRIII
and FcgRIV and the inhibitory IgG
receptor FcgRIIB (Nimmerjahn and
Ravetch, 2008). FcgRIII represents the
murine orthologue of human FcgRIIA, a
corresponding counterpart of the hu-
man FcgRIIIB is absent in mice (Sup-
plementary Table S1 online). Murine
FcgRIV, however, is represented in
humans by its ortholoque FcgRIIIA.
Therefore, concerning the role of FcgR,
a direct transfer of findings derived
from mouse models of BP to the human
disease is not possible. In this study,
we aimed at defining the role of
human FcgRs in the activation of
neutrophils in BP.
In a first set of experiments, we
attempted to determine the contribution
of individual FcgR to the pathogenesis
of BP using the ex vivo cryosection
model of the disease (Sitaru et al.,
2002b). The role of individual FcgRs
was analyzed by preincubation of
leukocytes with blocking antibodies
directed against FcgRI, FcgRII, or
FcgRIII, respectively, or an appropriate
isotype control. Cells were subjected to
skin cryosections treated with patient
sera, and dermal–epidermal separation
was determined by light microscopy.
Although a strong separation was
seen in sections where leukocytes
received no or isotype control antibo-
dies (78 and 60% separation of the
entire length of the dermal–epidermal
junction, respectively), no splits were
detected in sections incubated with
normal human serum (Figure 1). Treat-
ment of leukocytes with antibodies
directed against FcgRII or FcgRIII re-
sulted in a dramatic decrease in derma-
l–epidermal separation (86 and 88%
reduction as compared with the posi-
tive control, respectively). However, no
such inhibition was observed when
leukocytes received antibodies to FcgRI
(Figure 1). These results indicate that
both FcgRII and FcgRIII, but not FcgRI,
mediate autoantibody-induced derma-
l–epidermal separation. Although the
results derived from the ex vivo model
of BP clearly show that FcgRII andAbbreviations: BP, bullous pemphigoid; IC, immune complex; ROS, reactive oxygen species
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FcgRIII are involved in tissue damage,
the individual cellular functions con-
tributing to activation of the different
receptors remained unclear. To
address this question, we established
an in vitro assay allowing to analyze
neutrophil functions, including exocy-
tosis and production of reactive oxygen
species (ROS), which have been shown
to be essential for blistering in auto-
immune bullous diseases (Chiriac
et al., 2007). To mimic tissue-bound
ICs, plastic surfaces were coated
with recombinant murine type XVII
collagen (mCOL17) and subsequently
incubated with rabbit anti-mCOL17
IgG to form immobilized ICs (Supple-
mentary Materials and Methods online).
Freshly isolated neutrophils were ex-
posed to these IC and neutrophil
exocytosis, production of ROS as well
as neutrophil morphology were mon-
itored (Supplementary Materials and
Methods online). Exposure of neutro-
phils to immobilized IC resulted in an
immediate production of ROS, neutro-
phil exocytosis, and neutrophil spread-
ing, whereas untreated control cells or
cells, which had received mCOL17 in
the presence of normal rabbit IgG,
remained quiescent (Supplementary
Figure S1 online).
Next, we analyzed the individual
contribution of different FcgRs to
IC-mediated neutrophil activation.
Flow cytometric analysis revealed that
neutrophils expressed high levels of
FcgRIII and moderate levels of FcgRII
on their surface, whereas FcgRI could
not be detected under our experimental
conditions (Figure 2a), confirming
that human neutrophils express the
low-affinity IgG receptors FcgRIIA and
FcgRIIIB. Stimulation with IC did not
induce the expression of FcgRI or
modulate FcgRIIIB, whereas a slight
reduction of FcgRIIA was observed.
Furthermore, ROS production induced
by immobilized IC was completely
inhibited in the presence of either
anti-FcgRII or anti-FcgRIII antibodies,
whereas preincubation of cells with
anti-FcgRI blocking antibody or isotype
control IgG did not affect the formation
of ROS (Figure 2b). In addition, block-
ing antibodies directed against FcgRII
and FcgRIII also significantly reduced
neutrophil exocytosis in response to IC
by 95 and 73%, respectively, as com-
pared with the control cells (Figure 2c).
A combination of both antibodies did
not further increase this effect (data not
shown). Irrelevant control IgG or anti-
FcgRI antibody did not affect the
exocytosis response. Finally, we deter-
mined the effect of FcgR blocking
antibodies on neutrophil morphology.
Although IC-activated neutrophils, in
the absence of antibodies or in the
presence of either anti-FcgRI-antibodies
or an isotype control, spread on the
surface, preincubation of cells with
antibodies directed against FcgRII or
FcgRIII drastically inhibited neutrophil
spreading. Interestingly, eosinophils
express FcgRIIA on their surface and
produce ROS in response to IC (Supple-
mentary Figure S2 online). Although
this may indicate that eosinophils can
principally contribute to the disease,
because of their limited numbers (1–3%
of total cells) in our neutrophil prepara-
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Figure 1. The role of Fcc receptors (FccRs) in autoantibody-mediated dermal separation ex vivo. Human
skin cryosections were incubated with sera derived from bullous pemphigoid patients for 1 hour, as previously
described (Sitaru et al., 2002b). Subsequently, freshly isolated human peripheral leukocytes from healthy
donors, preincubated with the anti-FcgR antibodies indicated or a corresponding isotype control, were added.
Sections of a representative experiment are shown (a). Arrows indicate the dermis–epidermis separations.
Bar¼200mm. Furthermore, skin separation was quantified as percentage of epidermis detached from dermis
by an observer blinded to the applied sera/antibodies (b). Data are presented as mean±SEM
of three independent experiments. *Indicates statistically significant differences (Po0.01).
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tions, their role in our study can be
neglected.
In summary, our results show that
FcgRIIA and FcgRIIIB are required for
neutrophil-mediated dermal–epidermal
separation in the ex vivo model of
human BP. Our findings extend previous
studies in murine models of the disease,
where FcgRIII has been identified as key
regulator of tissue damage. The observed
differences between human and murine
cells may be highly relevant for the deve-
lopment of future therapeutic strategies
to BP and other antibody-mediated auto-
immune diseases.
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Figure 2. Effect of blocking antibodies to Fcc receptors (FccRs) on neutrophil activation by immobilized immune complexes (ICs) in vitro. (a) Expression
of FcgRs on human neutrophils. Neutrophils were stained against FcgRI, FcgRII, FcgRIII, or a corresponding isotype control, respectively, before (upper panel) or
after (lower panel) exposure to IC. (b) Reactive oxygen species (ROS) production. Neutrophils were pretreated for 30 minutes with blocking antibodies
against FcgRs (10mg ml1) or a corresponding isotype control and exposed to IC. Generation of ROS was determined by measurement of chemiluminescence.
One representative result out of three is given. (c) Neutrophil exocytosis. Degranulation was determined by the amount of lactoferrin released (Kasper et al.,
2004). Release rates of IC-treated cells (8.1–18.5% of total lactoferrin) were set as 100%, and release rates of antibody-treated cells as well as unstimulated
samples (negative control) are given as percentage of these control cells. Data are presented as mean±SEM, n¼3, *Po0.05 and **Po0.001. (d) Morphology
of neutrophils exposed to uncoated (negative control) or IC-coated surfaces in the presence of different antibodies. Photographs of one representative experiment
out of three are given. Bar¼25 mm; RLU, relative light unit.
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TO THE EDITOR
Sporadic melanoma is associated with
high frequencies of somatic mutations
in BRAF, a serine–threonine kinase
acting in the mitogen-activated protein
(MAP) kinase pathway (Michaloglou
et al., 2008). Mutations in the gene
arise mainly in tumors that develop on
skin with intermittent sun exposure
(Dhomen and Marais, 2007). The most
frequent mutation in BRAF, an A-to-T
transversion at nucleotide 1799, results
in a valine to glutamic acid change at
codon 600 (Michaloglou et al., 2008).
BRAFV600E is intrinsically activated with
a several-hundred-fold increase in basal
kinase activity. The possible association
between the BRAFV600E mutation and
germline variants in the pigmentation-
related melanocortin receptor 1 (MC1R)
gene has been the focus of several
studies in recent years. MC1R is the
major contributor to pigmentation di-
versity in humans (Rees, 2003). The
receptor gene is highly polymorphic,
with more than 100 variants, many
being nonsynonymous (Garcia-Borron
et al., 2005). The importance of MC1R
is accentuated by the association of its
variants with skin pigmentation varia-
tion, skin cancer risk, and the pene-
trance of germline CDKN2A mutations
(Box et al., 2001; Sulem et al., 2007;
Scherer et al., 2009). So far, studies on
the association between germline
MC1R variants and frequency of som-
atic BRAF mutations in melanoma
tumors have produced inconsistent
results—some researchers have sug-
gested that the presence of MC1R
variants increases the frequency of BRAF
mutations; others found no association
(Landi et al., 2006; Fargnoli et al.,
2008; Hacker et al., 2009; Thomas
et al., 2010).
In the present study, we investi-
gated the correlation between MC1R
variants and the most common somatic
BRAF/NRAS mutations in 202 paraffin-
embedded primary melanoma tissues.
Mutations in BRAF and NRAS were
detected using single-strand conforma-
tion polymorphism and confirmed
by sequencing. The MC1R gene was
screened in three fragments by direct
sequencing. Out of all 202 tumors,
63 (31%) were superficial spreading
melanoma (SSM), 84 (42%) were
Abbreviations: ALM, acral lentigeous melanoma; LMM, lentigeous malignant melanoma; MAP, mitogen-
activated protein; NM, nodular melanoma; PKA, protein kinase A; RHC, red hair color; SSM, superficial
spreading melanoma
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